You are here

Article info

Article menu

Download PDFPDF

Review
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option

Authors

  • Maartje W. Rohaan Department of Medical Oncology, The Netherlands Cancer Institute (NKI) Plesmanlaan 121 1066 CX Amsterdam The Netherlands PubMed articlesGoogle scholar articles
  • Joost H. van den Berg Biotherapeutics Unit, The Netherlands Cancer Institute Plesmanlaan 121 1066 CX Amsterdam The Netherlands Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute Plesmanlaan 121 1066 CX Amsterdam The Netherlands PubMed articlesGoogle scholar articles
  • Pia Kvistborg Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute Plesmanlaan 121 1066 CX Amsterdam The Netherlands PubMed articlesGoogle scholar articles
  • John B. A. G. Haanen Department of Medical Oncology, The Netherlands Cancer Institute (NKI) Plesmanlaan 121 1066 CX Amsterdam The Netherlands Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute Plesmanlaan 121 1066 CX Amsterdam The Netherlands PubMed articlesGoogle scholar articles
  1. ↵a m.rohaan{at}nki.nl
  2. ↵b jh.vd.berg{at}nki.nl
  3. ↵c p.kvistborg{at}nki.nl
  4. ↵d 0031 205126979 j.haanen{at}nki.nl
View Full Text

Citation

Rohaan MW, van den Berg JH, Kvistborg P, et al
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
Journal for ImmunoTherapy of Cancer 2018;6:102. doi: 10.1186/s40425-018-0391-1

Publication history

  • Received April 11, 2018
  • Accepted July 25, 2018
  • First published October 3, 2018.
Online issue publication 
February 10, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.